ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -12.5% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8 | 0.0% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8 | -33.3% | 2,400 | -11.1% | 0.00% | 0.0% |
| Q4 2022 | $12 | -99.9% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | -21.1% | 2,700 | -48.1% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -69.8% | 5,200 | -71.8% | 0.00% | -75.0% |
| Q1 2022 | $63,000 | -59.4% | 18,432 | -68.5% | 0.00% | -42.9% |
| Q4 2021 | $155,000 | -8.3% | 58,513 | +512.7% | 0.01% | 0.0% |
| Q3 2021 | $169,000 | +428.1% | 9,550 | +402.6% | 0.01% | +600.0% |
| Q2 2021 | $32,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |